For the Culture By The Culture. ISSN: 3064-9331.
The U.S. is on the brink of reclassifying marijuana as a Schedule III substance, acknowledging its medical benefits while reshaping the landscape for research, taxation, and public perception. Discover the implications of this pivotal change in our detailed analysis
As rumors swirl about a potential DEA announcement to reschedule cannabis, the implications for medical research and industry regulations could be transformative. Will the DEA's decision ignite a new era for cannabis in America? Stay tuned for a groundbreaking shift in drug policy dynamics.
As Louisiana edges closer to a pivotal transformation in cannabis policy, House Bill 707 proposes not just to legalize adult-use cannabis, but to overhaul the state's regulatory framework. This measure lays the groundwork for a potential economic boom and enhanced safety regulations, setting the stage for a profound shift in 2024 and beyond
Hawaii’s Senate halts a progressive bill to decriminalize cannabis, citing public safety concerns and fears of bolstering the unregulated market
Senator John Fetterman pushes for marijuana legalization in Pennsylvania, highlighting the inconsistency in state policies and the potential benefits of a regulated market. His proactive stance reflects a broader regional shift and a national conversation geared towards progressive drug policy reform
Explore how Trulieve is driving the campaign to legalize recreational cannabis in Florida, contributing nearly $40 million to the cause. Discover the details of the "Adult Personal Use of Marijuana" initiative and the hurdles it faces before the 2024 ballot
